#TechBio - Twitter Hashtag

about 5 hours ago

Insider and early venture capital shares are locked up for 180 days (until mid-April next year), keeping the actively circulating free float relatively tight. $IAM $NVDA $ARKG #TechBio #AIDrugDiscovery

0

1

0

20

Joe Timmons

@joetimmons79

about 21 hours ago

Apache 2.0, open source: https://t.co/AU5FCZUWPM #GoogleCloud #opensource #AgenticAI #MultiAgent #DrugDiscovery #TechBio #Pharma #Biotech #LifeSciences #AIforScience #Oncology #GenAI #AIAgents #DataSharing #BioPharma #MachineLearning #CompBio #HealthTech

0

1

0

18

Generative @GenerativeHQ

6 days ago

A stealth TechBio startup backed by Merantix Capital and Seedcamp needed a Director of Data Engineering among its first hires. We searched for a track record of joining at pre-seed and staying through a later raise. That hire is now VP of Engineering. #TechBio #StealthStartup

0

5

Babraham Research Campus @BabrahamUK

7 days ago

Have you seen the fantastic case study on Campus-based Cyclana Bio in the TechBio report from the BIA? https://t.co/Kn3NeJCTaz #TechBio #TechBioUK

0

76

inside predict

@popmemecoin

7 days ago

JUST IN: 🚨 Metis TechBio inks massive drug discovery deal with pharmaceutical giant Eli Lilly. The partnership is valued at a staggering potential of over $1 billion. ethereum:0x9e32b13ce7f2e80a01932b42553652e053d6ed8e #Crypto #TechBio

0

38

inside predict

@popmemecoin

7 days ago

JUST IN: 🚨 METiS TechBio and Eli Lilly partner in a massive AI drug-delivery deal. The agreement includes up to $1.1 billion in milestone payments driving biotech innovation. ethereum:0x9e32b13ce7f2e80a01932b42553652e053d6ed8e #Crypto #TechBio

0

55

inside predict

@popmemecoin

7 days ago

JUST IN: 🚨 Metis TechBio secures massive pharma partnership. The firm inked up to a 1.1 billion dollar deal with Eli Lilly for its advanced drug delivery tech. ethereum:0x9e32b13ce7f2e80a01932b42553652e053d6ed8e #Crypto #TechBio

0

66

Aureka Biotechnologies Inc

@AurekaBio

7 days ago

A new look. A bigger vision. 🚀 Our new website is live, featuring a brand-new company video! Discover how Aureka is bringing AI and biology together to reshape therapeutic discovery. Explore what's next: https://t.co/F8pqounRco #AIforBiology #TechBio

0

5

0

2

3K

BiopharmaTrend @BiopharmaTrend

about 2 months ago

Interestingly, @InSilicoMeds (Insilico Medicine) sketched out what an ageing virtual cell would look like. This and other #techbio stories in our weekly newsletter, Where Tech Meets Bio: https://t.co/13EyjIornn

1

2

0

203

LSMO @LSbyMO

2 months ago

Recursion #RXRX Is way too advanced in #AI #biotech / #techbio. I see no competitor here. My2Cents

Dominique Beaini

@dom_beaini

2 months ago

I ran Boltz-2 100 million times 🤯 A cell is shaped by billions of interactions between proteins, RNA, DNA and small molecules. Co-folding can now simulate some of these interactions at scale. So what can we do with all this data? Could it open a bottom-up path to Virtual Cells? Can it help us understand the limitations of co-folding models? And learn when they actually translate to biology? 🧵

dom_beaini's tweet photo. I ran Boltz-2 100 million times 🤯

A cell is shaped by billions of interactions between proteins, RNA, DNA and small molecules. Co-folding can now simulate some of these interactions at scale.

So what can we do with all this data?
Could it open a bottom-up path to Virtual Cells?

Can it help us understand the limitations of co-folding models? And learn when they actually translate to biology?

🧵

6

196

34

169

53K

0

3

1

0

503

Biotech Explained

@Explainbiotech

2 months ago

Biotech Snapshot #3 Recursion Pharmaceuticals ($RXRX) — an AI-native TechBio company trying to map biology at scale to discover drugs faster. Quick look at the science, the moat, the pipeline and the key risks. $RXRX #Biotech #BiotechInvesting #TechBio

Explainbiotech's tweet photo. Biotech Snapshot #3

Recursion Pharmaceuticals ($RXRX) — an AI-native TechBio company trying to map biology at scale to discover drugs faster.

Quick look at the science, the moat, the pipeline and the key risks.

$RXRX #Biotech #BiotechInvesting #TechBio https://t.co/5u9NcVKPMu

0

2

0

524

Hannah Gordon PhD, MSCI (she/her)

@brieski

3 months ago

“Be the change you want to see in the world” The change I want to see is more #biotech #techbio #AIbiotech companies making *actual* medicines. Anything short of that is not worth your attention. This is 1 of 3 in the clinic today. LFG 🚀

Enveda @enveda

3 months ago

Atopic Dermatitis needs new and better treatments. See what's around the corner. Link in the comments section. #AtopicDermatitis #Dermatology #DrugDiscovery #Biotech

1

7

2

0

661

0

3

0

260

Steve Crossan

@stevecrossan

3 months ago

Very much worth the time of anyone thinking about #techbio for range and insight

Jake P. Taylor-King

@wildtypehuman

3 months ago

Weekend reading: A roadmap for TechBio disruption in drug discovery Inner thoughts on how the industry works, and what could work for start ups entering the space. A blogpost with @Michael_JRYoung.

wildtypehuman's tweet photo. Weekend reading: A roadmap for TechBio disruption in drug discovery

Inner thoughts on how the industry works, and what could work for start ups entering the space. A blogpost with @Michael_JRYoung. https://t.co/z3k5Rw9SQb

11

162

26

238

34K

1

10

3

14

2K

January “Janus” Walker

@UtahPolitician

3 months ago

Read about #bitcoin and #mitochondria in https://t.co/MGJq1kF8Am #cancer #research #Neurosciences #physics #techbio #virtualcell #biotech

5

8

2

6

1K

Srika

@srika724

4 months ago

#techbio is still a thing but i think the frameworks have definitely changed. its more that the moat comes from a proprietary data flywheel, and in bio, a potential opportunity could be made out of failure data because model providers just can't generate it and pharma wont share it. so own that loop and live inside a regulated workflow and its not a wrapper anymore. just a guess though. excited to see how companies approach the data play now.

2

6

1

2

306

Esther Kim @gmofutures

4 months ago

I left Twitter when biotech funding dried up and dripped into AI. Serious question: Is #Techbio still a thing? For companies still building in this space: how do you defend a pure software play without hardware or wetware?

4

33

0

8

7K

MassBio @MassBio

4 months ago

We’re thrilled to announce the Drive 2026 #Techbio Track Review Board of industry leaders who are deeply committed to strengthening the early-stage innovation ecosystem: https://t.co/pfnwFFso0f

0

2

1

0

505

Seek Labs @seek_labs

5 months ago

Our CEO, Jared Bauer, joined @irat1onal on the @ProgressPotent1 podcast for a wide-ranging conversation on the future of biotech and what it will take to get there. #AI #TechBio #Innovation

seek_labs's tweet photo. Our CEO, Jared Bauer, joined @irat1onal
on the @ProgressPotent1 podcast for a wide-ranging conversation on the future of biotech and what it will take to get there.

#AI #TechBio #Innovation https://t.co/MupSXwaS8j

1

3

2

0

115

Altitude Lab @AltitudeLab

5 months ago

Altitude Lab portfolio companies surpass $205M in funding as startups advance clinical trials, sign global pharma deals, and reshape early-stage biotech. Full Press Release: https://t.co/nvEoBXc9vt #biotech #techbio #lifescience #utah

1

6

2

0

207